Blepharoptosis: Clinical Trials

2 trials for Blepharoptosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Blepharoptosis: new trials by email Literature Review of Blepharoptosis trials Research Report on Blepharoptosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LEV102 Topical Gel in Acquired Blepharoptosis
LEV102 1.0%, LEV102 2.0%, Vehicle - Acquired Blepharoptosis
Phase 1 / Phase 2CompletedLevation Pharma, Ltd.332023-02-232024-11-13
Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
RVL-1201, RVL-1201 Vehicle Placebo - Blepharoptosis
Phase 1 / Phase 2CompletedRVL Pharmaceuticals, Inc.462013-05-012021-11-26

Broader conditions

Eye Diseases (2)  ·  Eyelid Diseases (2)

Sponsors

Levation Pharma, Ltd. (1)  ·  RVL Pharmaceuticals, Inc. (1)

Countries

United States (2)

Top investigators

Chuck Slonim, MD (1)  ·  Houman D Hemmati, MD PhD (1)